← Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
CODITION hearing aid and speech therapy timing study
Also known as: CODITION, Speech therapy session, Hearing aid, 2022-A02788-35, NCT05946395
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Procedure/Rehab
Modality
Behavioral/Rehabilitation
Stage
Interventional/NA
Status
Discontinued
Target Gene
—
Route / Mode
Speech therapy plus hearing-aid fitting
Confidence
80%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-09
Geography
France
Population
older-adult, hearing-aid-user, speech-therapy, rehabilitation
Trial IDs
1
Mechanism
Randomized pilot design comparing synchronous versus delayed speech therapy alongside first-time hearing-aid fitting in older adults.
Indications
Notes
Corrected from an Euraxi-owned speech therapy record. ClinicalTrials.gov lists GCS Ramsay Sante as lead sponsor and Euraxi Pharma as industry collaborator. The study was withdrawn before enrolling patients.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, programType, stage, status, route...
IDs: NCT05946395, 2022-A02788-35, CODITION
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyindustry-collaborator-not-primary-sponsorwithdrawn-zero-enrolled
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed